The pandemic has magnified issues of gender equity that permeate medicine. Can it also be the catalyst for real change?
Lessons from this year’s vaccine drive could help future prevention campaigns, says expert.
As insurance companies start charging members for hospital-related costs again, analysis of 2020 data shows what they might owe.
Only 1 in 10 people with diabetes in low- and middle-income countries are getting evidence-based, low-cost comprehensive care.
Although the drug is commonly used to treat hepatorenal syndrome in other parts of the world, it lacks FDA approval. Researchers examine both its efficacy and safety.